专题:Neurological Disorders and Treatments

This cluster of papers focuses on the investigation of neuroprotective agents such as Citicoline and Cerebrolysin in the context of oxidative stress, ischemic stroke, brain injury, glaucoma, and neurodegenerative diseases like Alzheimer's. The research explores their mechanisms of action, effects on mitochondrial dysfunction, neuroprotection, and potential for promoting neuroregeneration.
最新文献
Efficacy and safety of ipidacrine (Neuromidin) in patients with diabetic polyneuropathy: results of an open-label comparative study

article Full Text OpenAlex

Efficacy and safety of minocycline in patients with acute ischaemic stroke (EMPHASIS): a multicentre, double-blind, randomised controlled trial

article Full Text OpenAlex

Catecholaminergic storm and extreme blood pressure lability induced by combined levodopa/benserazide, selegiline, and piribedil in Parkinson’s disease: a case report

article Full Text OpenAlex

Insulin Signaling in Alzheimer’s Disease: Association with Brain Insulin Resistance

article Full Text OpenAlex

2025 Highlights in new targets for migraine treatment

article Full Text OpenAlex

Serum biomarkers of postanoxic encephalopathy in relation to ghrelin treatment. A secondary analysis of the GRECO trial

article Full Text OpenAlex

Influencing factors of cognitive decline in elderly diabetic patients with hypertension and construction of a prediction model

article Full Text OpenAlex

Neuropeptide Cyclo-Prolylglycine: Discovery, Pharmacological Effects, and Mechanism of Action

article Full Text OpenAlex

Fortelyzin for acute ischaemic stroke treatment: an open, prospective, non-interventional, observational study FORPI registry

article Full Text OpenAlex

Autoregulation-Guided Blood Pressure Targets After Stroke Thrombectomy

article Full Text OpenAlex

近5年高被引文献
Role of Cholinergic Signaling in Alzheimer’s Disease

review Full Text OpenAlex 710 FWCI115.8686

Alzheimer’s Disease: Epidemiology and Clinical Progression

review Full Text OpenAlex 502 FWCI71.1568

Neurotransmitters—Key Factors in Neurological and Neurodegenerative Disorders of the Central Nervous System

review Full Text OpenAlex 499 FWCI45.7424

European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update

review Full Text OpenAlex 425 FWCI60.5654

The impact of triglyceride-glucose index on ischemic stroke: a systematic review and meta-analysis

review Full Text OpenAlex 267 FWCI58.7709

Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment

review Full Text OpenAlex 246 FWCI19.1857

Diabetes mellitus in the Russian Federation: dynamics of epidemiological indicators according to the Federal Register of Diabetes Mellitus for the period 2010–2022

article Full Text OpenAlex 221 FWCI27.7574

Japan Stroke Society Guideline 2021 for the Treatment of Stroke

article Full Text OpenAlex 211 FWCI31.1884

Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives

review Full Text OpenAlex 204 FWCI22.7858

New perspectives in diabetic neuropathy

review Full Text OpenAlex 186 FWCI33.2117